Unexplained Kidney Disease Spreads in US Without Classic Diabetes or High Blood Pressure Risk
Health experts track Chronic Kidney Disease of unknown origin in the US as cases emerge among workers who lack traditional medical risk factors like hypertension or diabetes.
By The Global Wire Newsroom · Reported from Alix Martichoux
Link preview · horizonglobalnews.com
Unexplained Kidney Disease Spreads in US Without Classic Diabetes or High Blood Pressure Risk
Health experts track Chronic Kidney Disease of unknown origin in the US as cases emerge among workers who lack traditional medical risk factors like hypertension or diabetes.
Public health officials and nephrology specialists are raising concerns over the domestic emergence of Chronic Kidney Disease of unknown origin (CKDu), a progressive renal condition that develops without the traditional physiological indicators typically associated with kidney failure. As detailed in reporting published by Alix Martichoux on September 20, 2026, individuals identified with CKDu do not present with classic metabolic and cardiovascular risk factors—most notably hypertension and type 2 diabetes—that account for the vast majority of kidney failure cases in clinical practice. The expanding reach of the illness across populations within the United States represents a significant epidemiological shift, bringing a health crisis historically studied in tropical agricultural regions into the domestic public health landscape and challenging established diagnostic protocols.
Key facts
What happened
The recognition of CKDu as an advancing public health concern inside the United States follows years of epidemiological observations in international labor sectors. Reporting by Alix Martichoux highlights that clinicians in various domestic jurisdictions are diagnosing irreversible renal decline in patients who lack any prior history of hypertension or diabetic hyperglycemia. These patients frequently present to healthcare facilities only after experiencing substantial, asymptomatic loss of kidney function, often at advanced stages requiring specialized renal care.
Standard medical screening for renal impairment traditionally focuses on individuals diagnosed with metabolic syndrome, high blood pressure, or advanced age. Because patients suffering from CKDu lack these classic indicators, the onset of the disease routinely goes undetected during standard medical evaluations. Clinical evaluation of affected individuals reveals a progressive decline in estimated glomerular filtration rate—the main metric used by nephrologists to evaluate kidney filtering capacity—without the urinary protein levels or vascular damage typical of diabetic nephropathy.
Medical researchers reviewing domestic case patterns note that affected individuals frequently share common occupational factors, including prolonged exposure to ambient heat, heavy physical exertion, and inadequate fluid replenishment during working hours. While historical data focused on coastal agricultural zones in Central America and South Asia, domestic clinicians are now recording similar clinical profiles across various regions of the United States.
Why it matters
The spread of CKDu into the domestic population carries significant consequences for clinical medicine, public healthcare economics, and occupational policy. In standard nephrology, clinical screening protocols rely on routine monitoring of blood pressure and blood glucose levels. When individuals without metabolic risk factors contract CKDu, the absence of traditional risk markers means diagnosis is frequently delayed until irreversible tissue damage has occurred. This diagnostic gap leaves patients vulnerable to end-stage renal disease without receiving early therapeutic interventions that can slow functional decline.
From an economic perspective, the expansion of non-traditional kidney disease places additional financial pressure on federal healthcare systems. Under federal program rules, individuals diagnosed with end-stage renal disease qualify for Medicare coverage regardless of age, making renal replacement therapy—including long-term hemodialysis and organ transplantation—a major long-term public expenditure. Treating advanced renal failure requires extensive specialized infrastructure and incurs high annual costs per patient. When working-age individuals lose kidney function prematurely, the economic impact extends to permanent disability claims and lost labor force productivity.
Furthermore, the emergence of CKDu exposes gaps in workplace protection frameworks. Outdoor labor sectors employ millions of workers exposed to thermal stress and high exertion. If workplace heat exposure and dehydration are primary drivers of renal injury, regulatory agencies face growing pressure to enforce protective operational standards. The current absence of distinct diagnostic coding for non-traditional kidney disease hinders workplace health authorities from quantifying the exact scope of occupational renal damage.
The background
To understand the significance of CKDu in the United States, it is necessary to examine the background of renal disease taxonomy and international epidemiology. Historically, chronic kidney disease (CKD) has been treated primarily as a secondary complication of underlying systemic disorders. In high-income nations, diabetes mellitus and essential hypertension together account for approximately 75 percent of all new end-stage renal disease cases. In these standard conditions, elevated blood pressure or sustained high blood glucose causes progressive damage to renal glomeruli, gradually impairing waste filtration.
By contrast, non-traditional chronic kidney disease was first documented as a distinct epidemiological phenomenon during the late 1990s and early 2000s. Public health researchers identified widespread renal failure among young male sugarcane harvesters along the Pacific coast of Central America, termed Mesoamerican Nephropathy. A similar pattern was independently identified among agricultural workers in Sri Lanka and parts of India. In those regions, affected workers were manual laborers operating in tropical heat who showed no clinical signs of diabetes, severe hypertension, or primary glomerulonephritis.
Biopsies of patients with non-traditional kidney disease reveal a clinical pathology distinct from classic diabetic kidney disease. Instead of glomerular sclerosis, microscopic examinations show tubulointerstitial nephritis accompanied by tubular atrophy and interstitial fibrosis. Researchers have proposed several interrelated hypotheses regarding its cause:
In the United States, occupational safety standards regarding heat hazards fall under the Occupational Safety and Health Administration (OSHA) and state agencies. While states such as California, Oregon, and Washington have enacted specific outdoor heat rules mandating rest and hydration, federal guidelines lack a universal outdoor heat standard.
Reaction
The reported spread of CKDu in the United States has prompted calls for action from public health researchers, occupational safety advocates, and nephrologists. Medical specialists are advocating for updated clinical guidelines that incorporate routine renal function testing—specifically serum creatinine and estimated glomerular filtration rate checks—for manual outdoor workers, regardless of whether they exhibit high blood pressure or diabetes.
Occupational health advocates note that current safety frameworks focus on preventing acute heat illness, such as heat stroke, while neglecting long-term organ damage from repeated thermal stress. Labor organizations are urging workplace regulators to enact comprehensive heat rules that mandate structured rest breaks in shaded areas, clean water access, and physiological monitoring.
Public health experts expect federal agencies such as the Centers for Disease Control and Prevention (CDC) and the National Institute for Occupational Safety and Health (NIOSH) to face increased requests from clinical researchers to establish national surveillance systems to track non-traditional renal disease metrics.
What we don't know yet
Several critical scientific and public health questions regarding CKDu remain unresolved:
What to watch
Key developments to monitor in the coming months and years include:
This account is based on original reporting by journalist Alix Martichoux.
How this story was produced
This report was written by The Global Wire newsroom from reporting first published by Alix Martichoux. We verify the core facts against the original report, write our own account, and add the background and consequences a short wire item leaves out. Drafting is AI-assisted inside an editor-supervised pipeline, and every story is checked for accuracy of attribution, structure and duplication before it appears — full detail in our AI and funding disclosure.
Spotted an error? Tell us at corrections@horizonglobalnews.com and read our corrections policy or editorial standards.






Reader comments
Loading comments…